Manager × security

Birchview Capital, LP BIODESIX INC holdings history

BIODESIX INC · CUSIP 09075X108 · CIK 1618205

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Birchview Capital, LP reported 286.80K BIODESIX INC (shares), valued at $6.47M, or 3.02% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
3.02%
Shares
286.80K
286,804
Reported value
$6.47M
USD

Shares unchanged; reported value increased 55.52%, and weight changed +0.65 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20263.02%286,804SEC filing ↗Filed Aug 14, 2026
Q1 20262.37%286,804SEC filing ↗Filed May 15, 2026
Q4 20251.14%286,804SEC filing ↗Filed Feb 13, 2026
Q3 20251.63%286,804SEC filing ↗Filed Nov 13, 2025
Q2 20251.61%5,736,113SEC filing ↗Filed Aug 14, 2025
Q1 20253.11%5,736,113SEC filing ↗Filed May 15, 2025
Q4 20247.14%5,736,113SEC filing ↗Filed Jun 30, 2025Amended
Q3 20248.76%5,696,113SEC filing ↗Filed Jun 30, 2025Amended
Q2 20248.04%5,696,113SEC filing ↗Filed Jun 30, 2025Amended
Q1 20246.22%5,348,273SEC filing ↗Filed Jun 30, 2025Amended
Q4 20237.66%5,348,273SEC filing ↗Filed Jun 30, 2025Amended

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20237.66%5,348,273$9.79MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Jun 30, 2025
Q1 20246.22%5,348,273$7.63MShares unchanged; reported value decreased 22.01%, and weight changed -1.44 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jun 30, 2025
Q2 20248.04%5,696,113$8.70MShares increased 6.50%; reported value increased 13.96%, and weight changed +1.82 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jun 30, 2025
Q3 20248.76%5,696,113$10.12MShares unchanged; reported value increased 16.34%, and weight changed +0.72 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jun 30, 2025
Q4 20247.14%5,736,113$8.78MShares increased 0.70%; reported value decreased 13.30%, and weight changed -1.62 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jun 30, 2025
Q1 20253.11%5,736,113$3.59MShares unchanged; reported value decreased 59.14%, and weight changed -4.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20251.61%5,736,113$1.62MShares unchanged; reported value decreased 54.86%, and weight changed -1.50 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20251.63%286,804$2.17MShares decreased 95.00%; reported value increased 33.77%, and weight changed +0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 20251.14%286,804$1.95MShares unchanged; reported value decreased 9.93%, and weight changed -0.49 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2026
Q1 20262.37%286,804$4.16MShares unchanged; reported value increased 113.24%, and weight changed +1.23 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20263.02%286,804$6.47MShares unchanged; reported value increased 55.52%, and weight changed +0.65 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Birchview Capital, LP · BIODESIX INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1618205","quarter":"2026Q2","cusip":"09075X108"}

get_institutional_manager_history
{"cik":"1618205","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.